Antioxidants from Rubus idaeus leaves: LC-MS/MS chemical profiling, in vitro antiglycation, α-glucosidase and α-amylase inhibitory activities

El Asri Sara Ben Mrid Reda Zouaoui Zakia Chibuye Bitwell Ennoury Abdelhamid Kabach Imad Nhiri Mohamed Chibi Fatiha a Laboratory of Biochemistry and Molecular Genetics,Faculty of Sciences and Technology of Tangier,Abdelmalek Essaadi University,Tetouan,Moroccob Institute of Biological Sciences (ISSB-P),Faculty of Medical Sciences (FMS),Mohammed VI Polytechnic University (UM6P),Ben-Guerir,Moroccoc Department of Chemistry,Mukuba University,Kitwe,Zambia
DOI: https://doi.org/10.1080/09603123.2024.2404248
2024-09-19
International Journal of Environmental Health Research
Abstract:The present study evaluated a range of biological activities of Rubus idaeus leaves, often considered as by-products, in relation to hyperglycemia. The antiglycation potential of this plant has not been previously reported. In this research, the methanolic leaf extract of R. idaeus was assessed for its antioxidant, enzyme inhibitory and antiglycation activities. The bioactive compounds present in the extract were screened using LC-MS/MS. Enzyme inhibitory activities were tested on α-glucosidase and α-amylase, and the antiglycation effect was investigated using BSA-fructose model. The methanolic extract showed a high polyphenolic contents (176.26 ± 2.26 mg GAE/g) and important IC 50 values for DPPH (34.79 ± 2.40 μg/mL) and ABTS radical scavenging activities (49.75 ± 2.47 μg/mL). In addition, the plant leaf extract significantly inhibited hyperglycemia-related enzymes in a dose-dependent manner and demonstrated a reduction in fluorescent AGEs, fructosamine, and dicarbonyl compounds. Therefore, R. idaeus cv Maravilla could be an effective source of therapeutics for improving the healthcare outcomes of diabetic patients.
public, environmental & occupational health,environmental sciences
What problem does this paper attempt to address?